Rapid Bio has taken part in the “Moscow R&D School” programme and, following the final module, concluded four agreements on joint research and experimental development projects.
The company’s new partners are Labadvance, a high-tech start-up based at the Skolkovo Institute of Science and Technology; the Frumkin Institute of Physical Chemistry and Electrochemistry of the Russian Academy of Sciences; Plekhanov Russian University of Economics; and the National Research Nuclear University MEPhI.
The “Moscow R&D School” is organised by the Moscow Innovation Cluster and the Skolkovo Moscow School of Management. Rapid Bio notes that the programme provides a space where scientific ideas can be turned into real technologies and helps to strengthen Russia’s innovation ecosystem. The new agreements are expected to deepen collaboration between researchers and industry and to support the development of next-generation diagnostic technologies.
The company’s new partners are Labadvance, a high-tech start-up based at the Skolkovo Institute of Science and Technology; the Frumkin Institute of Physical Chemistry and Electrochemistry of the Russian Academy of Sciences; Plekhanov Russian University of Economics; and the National Research Nuclear University MEPhI.
The “Moscow R&D School” is organised by the Moscow Innovation Cluster and the Skolkovo Moscow School of Management. Rapid Bio notes that the programme provides a space where scientific ideas can be turned into real technologies and helps to strengthen Russia’s innovation ecosystem. The new agreements are expected to deepen collaboration between researchers and industry and to support the development of next-generation diagnostic technologies.